Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004905 | PMC |
Infect Control Hosp Epidemiol
January 2025
Acute Communicable Disease Control, Los Angeles County Department of Public Health, Los Angeles, USA.
Introduction: Nursing home (NH) residents have an elevated risk of coronavirus disease 2019 (COVID-19) infection and severe outcomes. However, literature regarding outbreak outcomes at the facility level is limited.
Methods: NH outbreaks beginning between March 1, 2020, and February 22, 2022, at facilities under Los Angeles County jurisdiction were assigned to 1 of 6 time periods defined by dominant variants, surges in community transmission, and vaccination levels.
Plant Dis
January 2025
Guangdong Academy of Agricultural Sciences, Crop Research Institute, Wushan Road, Tianhe District, guangzhou, China, 510640;
Sweet potato ( (L.) Lam) is a major food crop that is cultivated in southern China (Huang et al. 2020).
View Article and Find Full Text PDFBurns
December 2024
Parkland Health, 5200 Harry Hines Blvd, Dallas, TX 75235, USA. Electronic address:
Health and racial disparities can limit access to preventative, trauma, and chronic disease care but have not been addressed in burn resuscitation. Over- and under-resuscitation contribute to increased overall hospital costs, and morbidity and mortality rates. The primary objective of this study was to identify potential racial disparities that may exist during the initial fluid resuscitation after burn injury.
View Article and Find Full Text PDFIntensive Care Med
December 2024
Department of Perioperative Medicine, Barts Health NHS Trust, London, UK.
Crohns Colitis 360
October 2024
Division of Gastroenterology, University of Washington, Seattle, WA, USA.
Background: Medically refractory Crohn's disease (CD) is associated with a high risk of complications. Mycophenolate mofetil (MMF), a small molecule immunosuppressant, has limited data in patients with CD, and objective endoscopic response to MMF has not been reported.
Aims: We evaluated the safety and clinical, endoscopic, and biochemical effectiveness of off-label MMF for refractory CD as monotherapy or in combination with a biologic in patients with CD.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!